ArticleMaterials today. Bio2026
Gallate-oriented surface engineering of lignin nanoparticles for enhanced antibacterial activity.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In combating bacterial infections, antibacterial nanomaterials offer a non-pharmacological alternative to conventional antibiotics. Biomass-derived lignin exhibits intrinsic antibacterial activity from polyphenolic motifs and can readily self-assemble into nanostructures due to its amphiphilicity. However, the formation of lignin nanoparticles (LigNPs) is governed by a delicate balance of noncovalent interactions, making assembly outcomes highly dependent on lignin source and fractionation process and thereby limiting precise control over the surface chemistry and functional-group presentation. Here we have developed a gallate-oriented surface engineering strategy that combines boronated lignin nanoparticles (BLigNPs) core with gallate derivatives (GDs) corona, enabling tunable surface chemistry and modulating their bactericidal activity to preferentially target Gram-negative or Gram-positive bacteria. Through spatially grafting redox-active pyrogallol moieties in a tannic acid (TA) corona, BLigNP-TA exhibited the highest antibacterial activity against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.